These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 14592937)

  • 1. Effect of stent coating alone on in vitro vascular smooth muscle cell proliferation and apoptosis.
    Curcio A; Torella D; Cuda G; Coppola C; Faniello MC; Achille F; Russo VG; Chiariello M; Indolfi C
    Am J Physiol Heart Circ Physiol; 2004 Mar; 286(3):H902-8. PubMed ID: 14592937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of elemene on inhibiting proliferation of vascular smooth muscle cells and promoting reendothelialization at the stent implantation site.
    Sun W; Huang Y; Yin T; Wang J; Du R; Qiu J; Zhang Y; Wang Y; Chen J; Wang G
    Biomater Sci; 2017 May; 5(6):1144-1155. PubMed ID: 28503689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Particle debris from a nanoporous stent coating obscures potential antiproliferative effects of tacrolimus-eluting stents in a porcine model of restenosis.
    Kollum M; Farb A; Schreiber R; Terfera K; Arab A; Geist A; Haberstroh J; Wnendt S; Virmani R; Hehrlein C
    Catheter Cardiovasc Interv; 2005 Jan; 64(1):85-90. PubMed ID: 15619311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antirestenotic effects of a novel polymer-coated d-24851 eluting stent. Experimental data in a rabbit iliac artery model.
    Lysitsas DN; Katsouras CS; Papakostas JC; Toumpoulis IK; Angelidis C; Bozidis P; Thomas CG; Seferiadis K; Psychoyios N; Frillingos S; Pavlidis N; Marinos E; Khaldi L; Sideris DA; Michalis LK
    Cardiovasc Intervent Radiol; 2007; 30(6):1192-200. PubMed ID: 17828426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arsenic trioxide eluting stent reduces neointima formation in a rabbit iliac artery injury model.
    Yang W; Ge J; Liu H; Zhao K; Liu X; Qu X; Li W; Huang Y; Sun A; Zou Y
    Cardiovasc Res; 2006 Dec; 72(3):483-93. PubMed ID: 17020754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Peroxisome Proliferator-Activated Receptor-δ as Novel Therapeutic Strategy to Prevent In-Stent Restenosis and Stent Thrombosis.
    Hytönen J; Leppänen O; Braesen JH; Schunck WH; Mueller D; Jung F; Mrowietz C; Jastroch M; von Bergwelt-Baildon M; Kappert K; Heuser A; Drenckhahn JD; Pieske B; Thierfelder L; Ylä-Herttuala S; Blaschke F
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1534-48. PubMed ID: 27283742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival of endothelial cells in vitro on Paclitaxel-loaded coronary stents.
    Prasad CK; Resmi KR; Krishnan LK; Vaishnav R
    J Biomater Appl; 2005 Apr; 19(4):271-86. PubMed ID: 15788425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local cyclin-dependent kinase inhibition by flavopiridol inhibits coronary artery smooth muscle cell proliferation and migration: Implications for the applicability on drug-eluting stents to prevent neointima formation following vascular injury.
    Jaschke B; Milz S; Vogeser M; Michaelis C; Vorpahl M; Schömig A; Kastrati A; Wessely R
    FASEB J; 2004 Aug; 18(11):1285-7. PubMed ID: 15180955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fludarabine prevents smooth muscle proliferation in vitro and neointimal hyperplasia in vivo through specific inhibition of STAT-1 activation.
    Torella D; Curcio A; Gasparri C; Galuppo V; De Serio D; Surace FC; Cavaliere AL; Leone A; Coppola C; Ellison GM; Indolfi C
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2935-43. PubMed ID: 17293493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic strain amplitude dictates the growth response of vascular smooth muscle cells in vitro: role in in-stent restenosis and inhibition with a sirolimus drug-eluting stent.
    Colombo A; Guha S; Mackle JN; Cahill PA; Lally C
    Biomech Model Mechanobiol; 2013 Aug; 12(4):671-83. PubMed ID: 22961302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of smooth muscle cell proliferation and endothelial regeneration after vascular injury and stenting: approach to therapy.
    Curcio A; Torella D; Indolfi C
    Circ J; 2011; 75(6):1287-96. PubMed ID: 21532177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug loaded nanoparticle coating on totally bioresorbable PLLA stents to prevent in-stent restenosis.
    Zhao J; Mo Z; Guo F; Shi D; Han QQ; Liu Q
    J Biomed Mater Res B Appl Biomater; 2018 Jan; 106(1):88-95. PubMed ID: 27875036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic effects of a novel nanoporous stent coating and tacrolimus on intima proliferation in rabbits.
    Wieneke H; Dirsch O; Sawitowski T; Gu YL; Brauer H; Dahmen U; Fischer A; Wnendt S; Erbel R
    Catheter Cardiovasc Interv; 2003 Nov; 60(3):399-407. PubMed ID: 14571494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human vascular smooth muscle cells from restenosis or in-stent stenosis sites demonstrate enhanced responses to p53: implications for brachytherapy and drug treatment for restenosis.
    Scott S; O'Sullivan M; Hafizi S; Shapiro LM; Bennett MR
    Circ Res; 2002 Mar; 90(4):398-404. PubMed ID: 11884368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basic fibroblast growth factor as a potential stent coating material inducing endothelial cell proliferation.
    Kitamura N; Hasebe T; Matsumoto T; Hotta A; Suzuki T; Yamagami T; Terada H
    J Atheroscler Thromb; 2014; 21(5):477-85. PubMed ID: 24366328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stent coating with titanium-nitride-oxide for reduction of neointimal hyperplasia.
    Windecker S; Mayer I; De Pasquale G; Maier W; Dirsch O; De Groot P; Wu YP; Noll G; Leskosek B; Meier B; Hess OM;
    Circulation; 2001 Aug; 104(8):928-33. PubMed ID: 11514381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eptifibatide-eluting stent as an antiproliferative and antithrombotic agent: in vitro evaluation.
    Chitkara K; Hogrefe K; Vasa-Nicotera M; Swanson N; Gershlick AH
    J Invasive Cardiol; 2006 Sep; 18(9):417-22. PubMed ID: 16954580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Arsenic trioxide eluting stents to prevent restenosis of injured iliac arteries in rabbits].
    Yang W; Ge JB; Liu HL; An Y; Liu XB; Tian Y; Qu XF; Li WM; Huang YL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jan; 34(1):14-8. PubMed ID: 16626542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation of nanoparticle-eluting stents by a cationic electrodeposition coating technology: efficient nano-drug delivery via bioabsorbable polymeric nanoparticle-eluting stents in porcine coronary arteries.
    Nakano K; Egashira K; Masuda S; Funakoshi K; Zhao G; Kimura S; Matoba T; Sueishi K; Endo Y; Kawashima Y; Hara K; Tsujimoto H; Tominaga R; Sunagawa K
    JACC Cardiovasc Interv; 2009 Apr; 2(4):277-83. PubMed ID: 19463437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of artemisinin on the proliferation and apoptosis of vascular smooth muscle cells of rats.
    Wang HY; Huang RP; Han P; Xue DB; Li HB; Liu B; Shan P; Wang QS; Li KS; Li HL
    Cell Biochem Funct; 2014 Mar; 32(2):201-8. PubMed ID: 24105880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.